Q4 2021 Holdings
Filed 2022-02-14 | 13 holdings | $27.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $23.2M | 90,057 | 86.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.1M | 216,143 | 11.6% |
| Pfizer Inc(PFE) | COM | 717081103 | $454.6K | 7,697,762 | 1.7% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $71.6K | 605,587 | 0.3% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $29.8K | 511,908 | 0.1% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $25.9K | 591,975 | 0.1% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $12.4K | 166,190 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $9.0K | 153,537 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $6.5K | 111,500 | 0.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $6.1K | 145,841 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $5.9K | 161,802 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $5.6K | 317,428 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $852 | 23,104 | 0.0% |